Corona virus, a virus emerged from China, Wuhan and has affected people all across the globe. An epidemic spread over many countries and territories. Corona virus also known as Covid-19 which is an acute respiratory syndrome. Symptoms of Covid-19 resembles cold, cough, and fever. However, infection could lead to pneumonia, severe acute respiratory syndrome, and even death in some cases.

World Health Organization WHO has estimated crude mortality rate of covid-19 between 3%- 4%.

A drug to cure corona virus has arrived

Yes, you heard it right!! Corona virus pandemic poses a demanding challenge to all the health workers. Many countries and research institutes have been single mindedly running in a scientific race to strive against corona virus by development of vaccine and doing proper test to get the positive reports through clinical trials.

A study has revealed that the most effective antiviral for Covid-19 is REMEDESVIR. Researchers have found that Remdesivir, a broad spectrum medication developed by Gilead Sciences; has been approved by people of JAPAN with severe symptoms of Covid-19. It may shorten the time taken to recover from the infection caused due to covid-19.

Remivir gets incorporated into viral RNA and prevents it being synthesized, halting viral replication. Remivir inhibited SARS-COV-2 replication in laboratory studies and was tested in one patient with COVID-19 in US. The patients symptoms improved respiratory conditions.

Remdesivir was manufactured to treat infectious virus in 2010 and in the year 2015 it was tested to treat Ebola virus. But it has shown some po

Gilead gets an authorization for remdesivir vaccine to treat corona virus

The Food and Drug Administration has allowed to use for Gilead Sciences’ remdesivir drug to treat Corona virus. The National Institute of Allergy and Infectious Disease, tested on about 1063 patients but reports are still to come and has released results from its study which shows Covid 19 can be recovered from Remdesivir , after 11 days, four days prior to the results of the normal medication on a positive patient.

Gilead, CEO told reporters “We would like to thank the collaborators who brought remdesivir to this point and many of our people who are part of this- in fact the caregivers’’

Gilead is donating 1.5 million vials of Remdesivir. Clinical trials 397 with severe covid19 is being recovered from remdesivir.

The National Institute of Health (NIH), AAD, scientists across the world have worked sincerely and efficiently to get the treatment of corona virus through Remdesivir.

Most important endorsement to Remdesivir

A couple of weeks ago, doctors from the University of Chicago Medicine discussed remdesivir research that involved 125 people in two Phase 3 trials. The results to the study revealed that most patients were severe, and most of them recovered faster than expected. Only two died. Those results were preliminary, as they were yet to be published.

A drug maker in china said it has started producing remdesivir vaccine, an experimental drug that has the potential to fight the novel corona virus, as China is speeding up with its effort to find a treatment for the widening outbreak.

REMDESIVIR for patent in China

Wuhan Institute of Virology of Chinese Academy of Science filed a patent for commercial use of remdesivir vaccine in China. They sought to secure this patent “out of national interest” and noted they were not interested in enforcement should foreign pharma companies seek to collaborate in China to stop the pandemic. China and Wuhan clinically tried remdesivir on 308 covid 19 patients with moderate symptoms.

Trump’s drug Dr. mule successfully tested remdesivir

Dr. Anthony Faucet, White House Health Advisor declared that data from a corona virus drug trial testing Gilead Sciences’ antiviral drug remdesivir showed “quite good news” and sets a new standard of care for Covid-19 patients. He even says, what remdesivir has proven is a drug to block this virus.It has shown the tremendous effects on the trials done and is working very well on the treatment of novel corona virus.

Few researchers are still waiting for the reports. Asia and other countries have also taken two new trials on remdesivir.

Phase III trial of remdesivir

Unlike traditional drug development, Gilead Sciences are attempting to evaluate an investigational agent alongside an evolving global pandemic. Multiple concurrent research studies are helping inform whether remdesivir is a safe and effective treatment for corona virus and how to best utilize the drug in its every possible way.

These study results complement data from the placebo-controlled study of remdesivir conducted by the National Institute for Allergy and Infectious Diseases and help to determine the optimal duration of treatment with remdesivir. The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with remdesivir. This is particularly very important in the setting of a pandemic which could help hospitals and healthcare workers in treating more patients in urgent need of care.